Airborne viruses such as SARS-CoV-2 represent a major challenge in healthcare, veterinary, and industrial settings. Effective air sampling is essential for early detection and risk mitigation.
To support this need, an independent laboratory has compared the performance of Coriolis Compact and Coriolis+ using the SARS-CoV-2 Omicron BA5 variant in a controlled 20 m³ test chamber.
An analysis protocol was used to study the samples in 2 different categories:
- Infectious fraction of the virus through cell-based assays
- Genomic fraction of the virus using RT-qPCR
Whether your priority is portability and ease of use or maximum sensitivity for genomic detection, this study helps clarify which instrument best fits your operational and technical requirements.
Access the full Application Note to explore the data in detail and choose the right solution for your air sampling strategy.
